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Summary
Macrocyclization of synthetic peptides by thioester-
ase (TE) domains excised from nonribosomal peptide
synthetases (NRPS) has been limited to peptides that
contain TE-specific recognition elements. To alter
substrate specificity of these enzymes by evolution
efforts, macrocyclization has to be detected under high-
throughput conditions. Here we describe a method to
selectively detect cyclic peptides by fluorescence
resonance energy transfer (FRET). Using this method,
picomolar detection limits were easily realized, pro-
viding novel entry for kinetic studies of catalyzed
macrocyclization. Application of this method also
provides an ideal tool to track TE-mediated peptide
cyclization in real time. The general utility of FRET-
assisted detection of cyclopeptides was demonstrated
for two cyclases, namely tyrocidine (Tyc) TE and cal-
cium-dependent antibiotic (CDA) TE. For the latter cy-
clase, this approach was combined with site-directed
affinity labeling, opening the possibility for high-
throughput enzymatic screening.
Introduction
A variety of peptides, glycopeptides, lipopeptides, li-
poglycopeptides, and polyketidyl-peptidyl hybrids have
macrocyclic structures in which the rigidity of the ring
skeletons constrains these natural products to bio-
logically active conformations [1–4]. In the biosynthesis
of these natural products, such as the macrolactone
antibiotic daptomycin [5], the macrolactone antifungal
fengycin [6], and the macrolactam antibiotics tyrocidine
[7] and friulimicin [8], by nonribosomal peptide synthe-
tases (NRPS), C-terminal 30–40 kDa thioesterase do-
mains (TE) introduce this conformational rigidity by act-
ing as macrocyclization catalysts [9]. Recent research
on recombinant TE domains provided insights into their
substrate selectivity and catalytic mechanism and al-
lowed the chemoenzymatic generation of novel macro-
cyclic compounds [10, 11].
The chemoenzymatic approach combines the strength
of synthetic peptide synthesis with the strength of stereo-
selective and regioselective TE domain cyclization. How-
ever, a limitation of this strategy is the high enzymatic*Correspondence: marahiel@chemie.uni-marburg.de
1Present address: The Scripps Research Institute, Cravatt Labora-
tory, 10550 North Torrey Pines Road, La Jolla, California 92037.selectivity of TE domains for cognate substrates, which
can be a disadvantage when the cyclization of sub-
strate analogs is desired. Exchanges of C- and N-ter-
minal residues of the linear peptide substrate often
abolish formation of the macrocyclic product [2]. In
other cases, the yield of enzymatically generated ring
formation dramatically suffers from linear hydrolytic by-
products due to nucleophilic attack of water molecules
onto the acyl-enzyme intermediate [12]. Recently, it
was shown that the addition of nonionic detergent sig-
nificantly improves the cyclic to hydrolyzed product
ratio of the excised TE domain from the tyrocidine syn-
thetase [13]. Nevertheless, since the utility of TE do-
mains strongly depends on substrate tolerance, effi-
cient turnover, and high product yield, there is a
constant need for engineered TE domains. This could
be achieved by directed protein evolution, as previously
shown for lipases [14]. However, such an approach re-
quires reliable detection of cyclized peptides under
high-throughput conditions.
Herein, we present the design and utility of fluores-
cent probes capable of accurately indicating enzyme-
mediated peptide cyclization via fluorescence reso-
nance energy transfer (FRET) [15]. These probes are
available via simple solid phase peptide synthesis and
are characterized by picomolar detection limits. Fluo-
rescence occurs by a process that comprises the exci-
tation of a tryptophan (Trp) residue that subsequently
transfers its energy to a nonproteinogenic kynurenine
(Kyn) residue; this excited chromophore then relaxes
via emission of blue light [16]. These two fluorophores
are originally found in the lipopeptide antibiotic dapto-
mycin, which was clinically approved under the trade
name Cubicin (Figure 1A). The Trp residue was pre-
viously shown to have a low fluorescence yield due to
energy transfer to the Kyn residue. Further, the relative
quantum yield of daptomycin-incorporated Kyn is 7.6
times greater than Kyn as a free amino acid, thereby
allowing Kyn fluorescence (emission wavelength λEm z
455 nm) to be a sensitive probe of daptomycin-phos-
pholipid membrane interactions [16]. This efficient en-
ergy transfer results from the spectral overlap between
the Trp donor emission (λEm z 330 nm) and Kyn accep-
tor absorption (excitation wavelength λEx z 350 nm)
[16, 17].
We recently showed that the C-terminal TE domain
excised from the nonribosomal CDA synthetase retains
autonomous macrocyclization activity with linear pep-
tide thioester substrates based on a primary sequence
analogous to daptomycin [18]. Interestingly, the linear
peptide precursor adopts a conformation that spatially
separates these two fluorophores, limiting the Kyn
emission process (Figure 1B). However, the cyclized
daptomycin analog adopts a conformation in which the
Kyn fluorophore is in close spatial proximity to the Trp
residue, allowing FRET to occur (Figure 1A). Therefore,
the Kyn fluorescence difference between the linear and
cyclized peptide can be exploited to reliably detect cy-
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874Figure 1. Fluorescence Resonance Energy
Transfer in Daptomycin
(A) Daptomycin is a branched cyclic nonribo-
somally assembled acidic lipopeptide pro-
duced by Streptomyces roseosporus. This
decapeptide lactone adopts a conformation
in which the kynurenine (Kyn) fluorophore is
in close spatial proximity to the tryptophan
(Trp) residue, allowing fluorescence reso-
nance energy transfer (FRET) to occur. The
methyl group of nonproteinogenic L-3-methyl-
glutamate is indicated by shading.
(B) The structure of a linear daptomycin de-
rivative is shown. The fluorescent residues
Kyn and Trp are highlighted.
(C) Emission spectra of the linear and cy-
clic daptomycin derivatives in methanol and
DMSO 9:1 (v/v): red line, linear daptomycin
derivative; black line, cyclic daptomycin de-
rivative; excitation wavelength = 280 nm.clized peptide under high-throughput conditions to greatly
facilitate protein evolution efforts.
Results and Discussion
Synthesis and Fluorescence Characteristics
of Linear and Cyclic Daptomycin Peptides
The cyclic lipopeptide antibiotic daptomycin is a trideca-
peptide that contains two fluorophores: tryptophan (Trp,
W) at the N terminus and kynurenine (Kyn, U) at the C
terminus (Figure 1A). The poor fluorescence yield of the
Trp residue situated between the C10-fatty acid and the
peptide headgroup was reported earlier [16]. It was as-
sumed that this poor Trp emission is due to fluorescence
resonance energy transfer (FRET), which results from
the combination of the proximity of the two fluorophores
and the overlap of the Trp emission spectrum (λEm z 330
nm) and Kyn absorption spectrum (λEx z 350 nm). The
proximity of these fluorophores mainly arises from the
lactone bond, which connects threonine at position 4
w
t
p
d
s
a
p
t
l
y
c
w
C
s
1
a
t
d
m
s
sith the C-terminal Kyn residue. We thus reasoned that
he energy transfer might be less efficient in the linear
eptide derived from daptomycin by opening of the
ecapeptide lactone ring (Figure 1B). Given this as-
umption, we chose to compare the fluorescence char-
cteristics of cyclic to linear daptomycin. The latter was
repared by solid-phase peptide synthesis, followed by
reatment with trifluoroacetic acid (TFA), triisopropylsi-
ane (TIPS), and water in a ratio of 95:2.5:2.5 (v/v) to
ield the linear peptide acid. For the generation of cy-
lic daptomycin (Figure 1A), linear peptidyl thiophenol
as converted to the macrolactone in the presence of
DA cyclase [18]. In the linear and cyclic daptomycin
equence, we replaced L-3-methylglutamate at position
2 by glutamate for synthetic reasons. To investigate the
ssumed distance-dependent energy transfer between
he two fluorophores Trp and Kyn, the linear and cyclic
aptomycin analogs were excited at 280 nm, followed by
easurement of the emission spectra. Fluorescence mea-
urements were carried out in methanol and dimethyl-
ulfoxide (DMSO) in a ratio of 9:1 (v/v) due to 2.1-fold
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875Kyn-fluorescence enhancement compared to 10% DMSO
in water (data not shown). Interestingly, the Kyn emis-
sion at 453 nm of the linear daptomycin analog is mini-
mal, resulting in a 4-fold difference between linear and
cyclic peptide (Figure 1C). According to our model (Fig-
ure 2A), two different energetic pathways for the linear
and cyclic daptomycin analogs are proposed. In case of
the linear peptide, excitation at 280 nm produces prefer-
entially UV light (λem z 330 nm). Conversely, excitation
of Trp in the cyclic peptide generates a strong Kyn
emission in the visible region of light (λem z 455 nm)
due to FRET. This shows that the linear peptide adopts
random coil conformation that spatially separates the
two fluorophores, whereas the cyclized peptide adopts
a conformation in which Trp and Kyn are in close spatial
proximity, allowing FRET to occur. Further proof was
obtained by analytical HPLC in combination with fluo-
rescence studies (Figure 2B). An assay with 200 M
linear (ln) daptomycin-like peptide precursor lnDap-Figure 2. Proposed Model for the Energetic Interactions between
Trp and Kyn
(A) In case of the linear daptomycin derivative (Figure 1B), excita-
tion at 280 nm preferentially leads to emission of Trp. After cycliza-
tion (Figure 1A), this emission at w330 nm is efficiently quenched
due to fluorescence resonance energy transfer (FRET), which in-
duces fluorescence of Kyn in the visible region of light.
(B) Fluorescence enhancement by TE-mediated peptide cyclization
is shown. An assay containing 200 M linear peptidyl thioester
(lnDap-U1W13) and 5 M CDA TE was quenched by aqueous TFA
and analyzed by HPLC: upper HPLC trace, absorbance at 215 nm;
lower HPLC trace, fluorescence at 452 nm (excitation wavelength =
280 nm). Su, substrate; Hy, hydrolyzed product; Cy, cyclized prod-
uct. The fluorescence signal is slightly shifted to higher retention
times, because the solvent reaches the fluorescence detector after
passing the UV-detection cell.U1W13 (comprising Kyn at position 1 and Trp at position
13; Figure 3 shows the corresponding cyclic peptide
cyDap-U1W13) and 5 M CDA cyclase was quenched
after a time period of 30 min by the addition of aqueous
trifluoroacetic acid (TFA). Analytical HPLC with monitor-
ing at 215 nm revealed identical concentrations of pep-
tidyl thiophenol substrate and its macrolactone product
(Figure 2B). Remarkably, determination of the emission
at 452 nm using a fluorescence detector at an excita-
tion wavelength of 280 nm significantly enhanced sig-
nal intensity of the decapeptide lactone. Peak area in-
tegration exhibited a 5.5-fold amplification of visible
fluorescence in comparison to the linear precursor, in-
dicating a greatly improved energy transfer between
Trp and Kyn in the cyclic peptide.
Examination of Distance-Dependent Interactions
between Donor and Acceptor
We reasoned that the above FRET experiments could
be transferred to a variety of peptides with varying spa-
tial proximity of donor and acceptor. To investigate the
feasibility of FRET-detected peptide cyclization, we
chose to create a small library of linear and cyclic dap-
tomycin-like peptides (Figure 3). In contrast to authen-
tic daptomycin, the positions of the fluorophores Trp
and Kyn in the peptide backbone were exchanged. This
strategy maximizes the yield of cyclic peptide gener-
ated by CDA TE because Trp is the C-terminal amino
acid of cognate CDA [19]. Therefore, in all cases the
conversion to cyclic product was sufficient to allow
fluorescence studies (data not shown). To vary the dis-
tance between both fluorophores, Trp was kept at the
C terminus, whereas the position of Kyn was systemati-
cally altered. All of the HPLC-purified linear and cyclic
peptides were dissolved in a mixture of methanol and
DMSO 9:1 to a final concentration of 200 M, followed
by fluorescence measurements.
Since the distances between the fluorophores were
systematically altered in the above-mentioned library of
linear and cyclic (cy) daptomycin derivatives (Figure 3),
we expected a distance-dependent relationship of in-
tegrated acceptor fluorescence to integrated donor
fluorescence (EmKyn/EmTrp ratio). As shown in Figure
4A, the EmKyn/EmTrp ratio changes in the order cyDap-
U1W15 < cyDap-U1W14 < cyDap-U1W13 < cyDap-U2
W13 < cyDap-U3W13 < cyDap-U5W13 > cyDap-U7W13.
Therefore, decreasing distance between both fluoro-
phores clearly correlates with more effective energy
transfer. Indeed, the compounds cyDap-U3W13 and cy-
Dap-U5W13, the latter one with the fluorescent Kyn
moved to a ring position, show the highest EmKyn/EmTrp
ratios of this study because the FRET pair is separated
only by the cyclization nucleophile threonine.
In general, excitation at 280 nm revealed 3- to 5-fold
increased EmKyn/EmTrp ratios, when the linear peptide
precursors were converted into the corresponding
macrolactones by CDA cyclase, suggesting that the
Trp-Kyn pair may be employed as a reliable FRET probe
to monitor enzyme-catalyzed peptide cyclization. The
only exceptions were lnDap-U1W15 and lnDap-U1W14,
where peptide cyclization yielded less than 2-fold in-
creases of the EmKyn/EmTrp ratios (Figure 4A), indicating
that more than three amino acid residues in between
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876Figure 3. Macrocyclic Peptides Used in This Study
All fluorophore-tagged cyclopeptides are shown using 3 letter amino acid codes. The FRET pair in each compound is highlighted. The figures
in the middle of the macrocycles denote the number of amino acid residues between Trp and Kyn. Macrolactonization/macrolactamization is
indicated by gray shading. Kyn, kynurenine; Orn, ornithine; FA, fatty acid.Trp and Kyn significantly limits the energy transfer.
These results indicate that the fluorophores can be po-
sitioned at various sites of the peptide backbone to al-
low efficient FRET, clearly demonstrating that FRET-
assisted detection of peptide cyclization is not limited
to the special case of daptomycin. Detection of peptide
cyclization by FRET may also be applicable to many
different cyclopeptides by simple incorporation of the
fluorophores Trp and Kyn into the N- and C-terminal
parts of the peptide backbone.
Real-Time Monitoring of Peptide Cyclization
Cyclase-catalyzed macrolactonization/macrolactamiza-
tion is usually monitored by quenching of enzyme as-
says at various time points, followed by HPLC-MS
analysis on reverse-phase columns [20]. Quenching
can be conducted either by addition of diluted TFA or
by addition of organic solvents to irreversibly denature
the enzyme. To this end, the FRET-assisted detection
of peptide cyclization provides a useful means to follow
reactions in real time without disrupting enzymatic in-
tegrity. By incorporating fluorescent amino acids into
linear peptide precursors, adding the respective recom-
binant cyclization enzyme, and measuring the visible
fluorescence intensity (λ = 280 nm; λ = 452 nm)
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VEx Emt defined time intervals, one can easily estimate the
rogression of the peptide cyclization reaction. We
emonstrated this technique with the daptomycin de-
ivative lnDap-U3W13 in which the fluorescent residues
rp and Kyn were placed at positions 13 and 3, respec-
ively (Figure 3). After addition of 5 M CDA cyclase,
luorescence intensity at 452 nm followed a time-
ependent hyperbolic function, reaching a maximum
fter approximately 50 min (Figure 5A). HPLC studies
evealed total conversion to cyclic product within this
eriod of time. Also, a control reaction in the presence
f the corresponding heat-denatured enzyme indicated
o significant change in fluorescence emission.
The real-time monitoring of CDA cyclase-mediated
eptide cyclization raised the question of whether this
pproach may be applicable to other peptide cycliza-
ion catalysts. To answer this question, we chose the
ell-characterized tyrocidine synthetase thioesterase
omain (Tyc TE), which efficiently catalyzes head-to-tail
yclization with decapeptidyl thioesters. It was pre-
iously shown that Tyc TE tolerates replacement of resi-
ues 2–8 of peptidyl thioesters [7, 21]. To follow Tyc
E-catalyzed macrolactamization by FRET, we incorpo-
ated the Trp/Kyn pair into the wild-type tyrocidine A
equence. Specifically, we replaced Pro2 by Kyn and
al by Trp (Figure 3 shows the corresponding cyclic8
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877Figure 4. Fluorescence Studies of Linear and Cyclic Daptomycin
Derivatives
Determination of EmKyn/EmTrp ratios of linear and cyclic dapto-
mycin derivatives with systematically altered distance between Trp
and Kyn: linear daptomycin derivatives, white bars; cyclic dapto-
mycin derivatives, gray bars. All bars represent mean values of
three measurements. Excitation wavelength = 280 nm. U, kynure-
nine; W, tryptophan. The error bars represent the standard error of
the mean.1 13Figure 5. Real-Time Monitoring of Peptide Cyclization
(A) Sample contained 75 M lnDap-U3W13 and 5 M CDA TE
(square). The negative control was conducted in the presence of 5
M heat-denatured CDA cyclase (triangle).
(B) The cuvette contained 50 M lnTyc-U2W8 and 0.5 M Tyc TE
(square). The negative control was done in the presence of 0.5 M
heat-denatured Tyc TE (triangle). Excitation wavelength = 280 nm,
emission wavelength = 452 nm.peptide cyTyc-U2W8). Incubation of the resulting sub-
strate lnTyc-U2W8 with Tyc TE indicated a time-depen-
dent increase in fluorescence emission (λEm = 452 nm)
(Figure 5B), although the cyclization-to-hydrolysis ratio
was quite low (0.28) as determined by analytical HPLC.
Finally, no change in fluorescence was observed for
heat-denatured Tyc TE.
In conclusion, this study offers a simple means to
evaluate reaction progression of catalyzed macrolac-
tonization/macrolactamization by FRET. The results
also provide evidence that the position of the Trp fluo-
rophore is not restricted to the C terminus of the linear
peptide precursor, as demonstrated by the substrate
lnTyc-U2W8. Therefore, this observed high flexibility in
primary sequence makes FRET-assisted detection of
cyclopeptides a general tool for peptide cyclases.
Fluorescence Resonance Energy Transfer Can Be
Used to Measure Kinetics of Enzyme-Mediated
Peptide Cyclization
The above-mentioned results show that the close spa-
tial proximity of donor and acceptor in the cyclic pep-
tide induces up to 5.5-fold amplification of visible fluo-
rescence in comparison to the linear precursor. In
addition, FRET-assisted detection of peptide cycliza-
tion easily realizes picomolar detection limits using
conventional fluorescence detectors without optimiza-
tion. For example, the cyclic daptomycin derivative cy-
Dap-U2W13 was characterized by a detection limit of 7
pmol, whereas its linear counterpart lnDap-U2W13
showed a limit of 28 pmol. This high sensitivity raised
the question of whether FRET can be used to accu-
rately determine kinetics of enzyme-mediated peptide
cyclization. To address this question, thioester sub-
strates of daptomycin derivatives (lnDap-U W andlnDap-U3W13) were chosen for kinetic measurements,
which were performed by analytical HPLC combined
with fluorescence detection. Initial investigations re-
vealed a linear correlation between fluorescence emis-
sion at 452 nm and the concentrations of the respective
cyclic peptides (cyDap-U1W13 and cyDap-U3W13) as
determined by calibration curve plots, thus allowing
simple quantification of the fluorophor-containing macro-
lactones. Kinetic characterization of the cyclization re-
actions was then carried out by calculating the initial
reaction rates at 5–7 substrate concentrations. We
found that the kcat/KM values derived from integrated
fluorescence emission were in good agreement with the
corresponding kcat/KM values determined by UV absor-
bance at 215 nm, resulting in 1.2- to 1.6-fold differences
between both detection methods (Table 1).
FRET-Assisted Detection of Peptide Cyclization
of Immobilized CDA Cyclase
It has recently been shown that the use of NRPS-
derived peptide carrier protein (PCP) for biotin labeling
is amenable to high-throughput enzymatic screening
[22], which can be a powerful method for identifying
and evolving biological catalysts. The PCP is a versatile
tag for labeling PCP fusion proteins due to its small
Chemistry & Biology
878Table 1. Determination of Cyclization Kinetics Including Standard
Errors: UV Absorption versus Kyn Fluorescence
kcat/KM
Compound (mM−1min−1) Method
lnDap-U1W13 5.09 ± 4.25 absorbance (215 nm)
6.13 ± 4.17 fluorescence: emission
wavelength = 452 nm
lnDap-U3W13 4.34 ± 1.85 absorbance (215 nm)
6.75 ± 2.39 fluorescence: emission
wavelength = 452 nm
U = kynurenine, W = tryptophan, and ln = linear.
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gsize (80 amino acids) and its good portability to various
target proteins [23]. This autonomously folded domain
directs the specific biotin labeling of the target protein
in a complex mixture of cellular proteins, which is effi-
ciently catalyzed by the promiscuous 4#-phosphopan-
tetheinyl transferase Sfp from B. subtilis [24]. We there-
fore reasoned that this method could be transferred to
high-throughput screening of TE domains in order to
improve or alter their substrate specificity by directed
evolution efforts.
Since in the native context of NRPS, the PCP domain
is N-terminally associated with the TE domain, we sim-
ply excised the PCP-TE didomain from the synthetase.
Specifically, we heterologously expressed CDA PCP-
TE, a 44.5 kDa protein from the S. coelicolor CDA bio-
synthetic machinery that was fused to an N-terminal
heptahistidine tag [19]. The yield of the didomain was
around 4–5 mg/l. The purified CDA PCP-TE was then
labeled with Ppant biotin in the presence of Sfp and
biotin CoA as described earlier [23]. Site-directed post-
translational modification was allowed to proceed for
90 min at 30°C, followed by confirmation with an API
Qstar Pulsar i Q-q-TOF mass spectrometer (measured
mass m/z 45382, calculated mass 45379). The labeling-
reaction mixture was then run over an avidin column
(bed volume 1 ml). After washing the column, the immo-
bilized CDA PCP-TE didomain was incubated with 5
mM of lnDap-U1W13 for 3 hr at 25°C. Reaction products
were eluted off the column, and the mixture was char-
acterized by HPLC/MS (Figure 6A). Interestingly, lnDap-
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dFigure 6. Immobilization of CDA Cyclase by
Site-Directed Posttranslational Modification
and Subsequent Detection of Reaction
Products
(A) HPLC trace of lnDap-U1W13 prior to cycli-
zation by immobilized CDA cyclase (red
trace). Immobilized CDA TE was incubated
with lnDap-U1W13 for 3 hr at 25°C (black
trace).
(B) Detection of generated cyclopeptide by
FRET. The red trace shows the fluorescence
signal of lnDap-U1W13 prior to loading onto
the column. The black trace shows the fluo-
rescence signal after CDA TE-mediated cy-
clization. Excitation wavelength = 280 nm,
emission wavelength = 452 nm.
omains do not tolerate exchanges of specific resi-1W13 was significantly converted to the macrolactone
roduct cyDap-U1W13. The observed cyclization-to-
ydrolysis ratio was 7.0, validating that the immobilized
DA cyclase retains excellent cyclization activity. Addi-
ionally, minor amounts of an octapeptide lactam derived
rom cyclization via Orn6 were detected as described pre-
iously [18]. In contrast to the desired macrolactone, this
yproduct is also generated in the absence of bound
DA cyclase, indicating its nonenzymatic origin. Finally,
he PCP-TE didomain was eluted with 5 mM biotin, and
he protein was identified with SDS-PAGE to yield a sin-
le band of correct size (data not shown).
Remarkably, the substrate conversion into products
as accompanied by a 3.5-fold increase in fluores-
ence emission at 452 nm (Figure 6B). This result sug-
ests that rapid detection of peptide cyclization by
RET can be transferred to immobilized TE domains,
hus making the PCP-TE-tagging approach amenable
o high-throughput enzymatic screening. We also con-
lude that this technique can be used with a variety of
RPS peptide cyclases and will further allow evolution
f their substrate selectivities. Moreover, PCP-TE tag-
ing could in principle be used to successively cyclize
ultiple linear peptide precursors in a combinatorial
ashion.
ignificance
ere we have shown a robust system for specifically
etecting macrocyclic peptides by fluorescence reso-
ance energy transfer (FRET). In this approach, pep-
ide cyclization catalyzed by NRPS-derived TE do-
ains brings the donor (Trp) and the acceptor (Kyn)
n sufficiently close proximity to enable efficient
RET. Trp and Kyn are readily incorporated into the
eptide backbone by well-established solid-phase
eptide chemistry and show excellent spectral over-
ap between the donor emission and acceptor absorp-
ion. A library of daptomycin-like peptides revealed
hat this approach allows variable positioning of the
luorophores in the N- and C-terminal parts of the
eptide sequence, which is significant given that TE
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879dues of their peptidic substrates. This high flexibility
in primary sequence makes FRET-assisted detection
of cyclopeptides a general tool for peptide cyclases,
as demonstrated for CDA TE and Tyc TE. Moreover,
picomolar detection limits and a linear correlation be-
tween acceptor fluorescence and cyclopeptide con-
centration are realized, thus allowing determination
of cyclization kinetics.
Rapid and sensitive detection of peptide cyclization
by FRET can be transferred to avidin-immobilized cy-
clases using site-directed biotin labeling of PCP-TE
didomains. This PCP-TE-tagging approach can serve
as a valuable tool in high-throughput enzymatic screen-
ing to alter the substrate specificity of peptide cy-
clases, thereby allowing the synthesis of novel cyclo-
peptides. Alternatively, the methodology developed
could be utilized for the combinatorial synthesis of
these macrocyclic compounds.
Experimental Procedures
Cloning and Expression of CDA TE and CDA PCP-TE
The cda te and cda pcp-te gene fragments were amplified by PCR
using the chromosomal DNA of S. coelicolor A3(2) as template [25].
The PCR reaction was carried out with Turbo DNA polymerase
(Stratagene). Amplification of cda te was performed using the oli-
gonucleotides 5#-AAA AAA GGA TCC CGC GGC GGC CGG GAG
CC-3# and 5#-AAA AAA AAG CTT GGC GAC CTC GGT CGA ATC
GAG CG-3#. For cda pcp-te, the following oligonucleotides were
used: 5#-AAA AAA GGA TCC CGC ACC GTC GAG GGC CGC TC-
3# and 5#-AAA AAA AAG CTT GGC GAC CTC GGT CGA ATC GAG
CG-3#. The PCR products of cda te and cda pcp-te were cloned
into the BamHI/HindIII site of a derivatized pQE60 vector (Qiagen).
DNA sequencing was performed by GATC Biotech on an ABI prism
310 genetic analyzer (Applied Biosystems). The plasmids were di-
rectly used to produce proteins with an N-terminal heptahistidine
tag. Overproduction of recombinant proteins was carried out in
E. coli XL1-Blue (Stratagene). Cells were grown to OD = 0.5 (600
nm), induced with 1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG), and again grown at 25°C for 3 hr. The recombinant proteins
were purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity chroma-
tography (Amersham Pharmacia Biotech). Dialysis into 25 mM
HEPES and 50 mM NaCl (pH 7.0) was carried out using HiTrap de-
salting columns (Amersham Pharmacia Biotech). The concentration
of the purified protein was determined spectrophotometrically
using the estimated extinction coefficient at 280 nm. After being
flash frozen in liquid nitrogen, the protein was stored at −80°C.
Synthesis of Linear Peptide Thioester Substrates
Linear peptides were synthesized on an Advanced ChemTech
APEX 396 peptide synthesizer (0.1 mmol scale, N-[(1H-benzotria-
zol-1-yl)(dimethylamino)methylene]-N-methylmethaniminium hexa-
fluorophosphate N-oxide/1-hydroxybenzotriazole (HBTU/HOBt) acti-
vation) by using 2-chlorotrityl resin derivatized with the appropriate
C-terminal amino acid using Fmoc-protected monomers except for
the N-terminal monomer of the linear tyrocidine derivative, which
was Boc protected. Nα-Fmoc protection of kynurenine was con-
ducted with 9-fluorenylmethyl succinimidyl carbonate (Fmoc-OSu)
as described previously [18]. The peptides were cleaved from the
solid support using 1:2:7 acetic acid:trifluorethanol:dichlorometh-
ane (DCM), then the protected peptides were precipitated with
n-hexane and the solvent was removed by rotary evaporation. To
make the peptide thioesters, the peptides (1 eq.) were dissolved
in DCM, and diisopropylcarbodiimide (DCC, 2 eq.), HOBt (2 eq.),
thiophenol or N-acetylcysteamine (10 eq.), and potassium carbon-
ate (2 eq.) were added [20]. The reaction was stirred at ambient
temperature for 3 hr. After removal of the DCM, the protected pep-
tide thioesters were treated with 95:2.5:2.5 trifluoroacetic acid
(TFA):water:triisopropylsilane (2 ml) at room temperature for 2 hr.
Precipitation of the peptide thioesters was carried out with ice-cold ether (30 ml). After centrifugation, the peptide thioesters were
dissolved in 50% acetonitrile/water and purified on a semiprepara-
tive 250/21 Nucleodur 100-5 C18 reverse-phase column (Macherey
and Nagel) by applying a gradient from 20% to 60% acetonitrile in
0.1% TFA/water over 30 min at a flow rate of 20 ml min−1. The
peptide thioesters were characterized by MALDI-MS or ESI-MS:
lnDap-U1W13 m/z 1717.2 ([M+H]+), calcd 1716.7; lnDap-U2W13 m/z
1716.3 ([M+H]+), calcd 1716.7; lnDap-U3W13 m/z 1717.0 ([M+H]+),
calcd 1716.7; lnDap-U5W13 m/z 1716.6 ([M+H]+), calcd 1716.7;
lnDap-U7W13 m/z 1717.0 ([M+H]+), calcd 1716.7; lnDap-U1W14 m/z
1773.9 ([M+H]+), calcd 1773.7; lnDap-U1W15 m/z 1830.3 ([M+H]+),
calcd 1830.8; lnTyc-U2W8 m/z 1569.9 ([M+H]+), calcd 1569.7.
Preparation of Cyclic Peptides for Fluorescence Studies
250 M peptidyl-thiophenol thioesters were incubated for 2–5 hr
with 5 M CDA cyclase in 25 mM HEPES, 50 mM NaCl, and 5%
DMSO (v/v) at pH 7.0 and room temperature. Reactions were moni-
tored with analytical HPLC and thin-layer chromatography (TLC) on
silica gel 60 F254 plates (Merck) and visualized under UV (365 nm).
The semipreparative scale assays were quenched by adding TFA
to a final concentration of 1.6% (v/v). After flash freezing in liquid
nitrogen, the samples were lyophilized overnight. The resulting sol-
ids were redissolved in 1 ml of 50% acetonitrile/water. Purification
of the cyclic products was carried out on a 250/10 Nucleodur
100-7 C18 reverse-phase column (Macherey and Nagel) by applying
a gradient from 35% to 45% acetonitrile in 0.1%TFA/water over 30
min at a flow rate of 8 ml min−1. Lyophilized cyclic peptides were
dissolved in methanol:DMSO 9:1 to a final concentration of 200
M. The purities were checked by analytical HPLC, and the con-
centrations were determined by comparing the area of absorption
at 215 nm with that of a known concentration of linear peptide
thioester or daptomycin. The cyclic peptides were characterized
by MALDI-MS or ESI-MS: cyDap-U1W13 m/z 1607.1 ([M+H]+), calcd
1606.7; cyDap-U2W13 m/z 1606.9 ([M+H]+), calcd 1606.7; cyDap-
U3W13 m/z 1607.0 ([M+H]+), calcd 1606.7; cyDap-U5W13 m/z 1606.8
([M+H]+), calcd 1606.7; cyDap-U7W13 m/z 1606.9 ([M+H]+), calcd
1606.7; cyDap-U1W14 m/z 1663.8 ([M+H]+), calcd 1663.7; cyDap-
U1W15 m/z 1721.0 ([M+H]+), calcd 1720.8; cyTyc-U2W8 m/z 1450.6
([M+H]+), calcd 1450.7.
Determination of kcat /KM Values
Kinetic characterization of the cyclization reactions was carried out
by determining initial rates at varying peptide thioester concentra-
tions. This was done by using two time points at each substrate
concentration within the linear region of CDA TE. The reactions
were carried out in 25 mM HEPES and 50 mM NaCl (pH 7.0) with
5% DMSO (v/v) at 20°C. The enzyme concentration used was 5
M. Quenching was accomplished by addition of 35 l of 4% TFA/
H2O. All assays were analyzed on a reverse-phase C18 Nucleodur
column (Macherey and Nagel, 125/3, pore diameter 100 Å, particle
size 3 m) with the following gradient: 0–10 min, 30%–90% aceto-
nitrile/0.1% TFA in water/0.1% TFA, 0.8 ml/min, and 40°C. Concen-
trations of cyclic products were determined using the area of ab-
sorption at 215 nm. Alternatively, concentrations of cyclic peptides
were calculated as the integrated fluorescence emission at 452 nm
using a fluorescence detector (Standard FLD cell, Agilent) at an
excitation wavelength of 280 nm (PMT gain 10). In both cases the
concentrations were determined by comparing the area of absorp-
tion at 215 nm or the area of emission at 452 nm with that of known
concentrations of the corresponding cyclic peptides (cyDap-U1W13
and cyDap-U3W13). Separate kcat and KM values could not be deter-
mined due to severe substrate inhibition at concentrations greater
than 200 M, which might be related to micelle formation of the
amphiphilic substrates [26].
Synthesis of Biotin CoA
Biotin CoA was prepared according to Yin et al. [22]. A solution of
biotin maleimide (Pierce) (10 mg, 19 mol) in 300 l DMSO was
added to coenzyme A lithium salt (Sigma) (18.2 mg, 23 mol) in 2 ml
MES acetate 50 mM at pH 6.0. After stirring overnight, the reaction
mixture was purified on a semipreparative 250/21 Nucleodur 100-5
C18 reverse-phase column (Macherey and Nagel) by applying a gra-
dient from 0% to 60% acetonitrile in 0.1% TFA/water over 35 min
Chemistry & Biology
880at a flow rate of 18 ml min−1. The purified product was charac-
terized by MALDI-MS: Biotin CoA m/z 1293.2 ([M+H]+), calcd
1293.3.
Peptide Cyclization by the Immobilized CDA PCP-TE Didomain
Sfp phosphopantetheinyl transferase-catalyzed biotin CoA labeling
of the purified CDA PCP-TE protein was performed according to
Clugston et al. [27]. In a total volume of 100 l, 5 M Sfp, 5 M
biotin CoA, 10 mM MgCl2, and 1 mM tris(2-carboxyethyl)phosphine
(TCEP) in 50 mM HEPES (pH 7.5) were incubated with 20 M CDA
PCP-TE didomain for 90 min at 30°C. The labeling reaction mixture
was then run over a column loaded with SoftLink soft release avidin
resin (Promega) (bed volume 1 ml). Incubation was carried out at
4°C prior to washing with a solution containing 5 ml 0.1 M NaPO4
(pH 7.0). 5 mM peptidyl thiophenol lnDap-U1W13 dissolved in 100
l DMSO was then added to the column. After incubation at 25°C
for 3 hr, the reaction products were eluted with 1 ml phosphate
buffer. After lyophilizing to dryness, the eluate was extracted with
methanol:DMSO 9:1. Product analysis was conducted by analytical
HPLC on a C18 Nucleodur column (Macherey and Nagel, 125/3,
pore diameter 100 Å, particle size 3 m) by applying a gradient
from 30% to 90% acetonitrile in 0.1% TFA/water over 10 min at a
flow rate of 0.8 ml min−1 and by fluorescence detection without
HPLC column (Standard FLD cell [Agilent], emission wavelength
452 nm, excitation wavelength 280 nm, PMT gain 10, injection vol-
ume 10 l, 100% methanol over 2 min, 0.5 ml min−1). The CDA
PCP-TE didomain was eluted with 5 mM biotin in the phosphate
buffer. The eluate was resolved by SDS-PAGE (12.5%) and visual-
ized by Coomassie stain.
Fluorescence Techniques
Fluorescence measurements were performed on a spectrofluo-
rometer (FP-6500, Jasco) with slits set to 10 nm (excitation) and 5
nm (emission) at an excitation wavelength of 280 nm. The detector
was set to low sensitivity. Constant temperature was achieved by
circulating water through the cell holder in which the temperature
was measured by a temperature controller (ETC-273T, Jasco). The
fluorescence results are expressed as the relative quantum yield
(f) calculated as the integrated fluorescence emission between 300
and 390 nm (Trp) and between 400 and 550 nm (Kyn). All experi-
ments were performed in 10 mm path length cuvettes containing
300 l of linear peptide thioester or cyclic peptide dissolved in
methanol:DMSO 9:1 to a final concentration of 200 M. Fluores-
cence measurements were also carried out using a fluorescence
detector (Standard FLD cell, Agilent) without HPLC column (emis-
sion wavelength 452 nm, excitation wavelength 280 nm, PMT gain
10, injection volume 10 l, 100% methanol over 2 min, 0.5 ml
min−1). Absorptions measurements were performed on an Ultro-
spec 3000 UV/Visible Spectrophotometer (Pharmacia Biotech).
Real-Time Fluorescence Measurements
Reactions were carried out in 10 mm path length cuvettes in a total
volume of 300 l with 25 mM HEPES, 50 mM NaCl, and 5% DMSO
(v/v) at pH 7.0 and 25°C. The enzyme concentrations were 0.5 M
for Tyc TE and 5 M for CDA cyclase. The negative controls were
conducted in the presence of the corresponding heat-denatured
enzymes. Reactions were initiated by addition of 50 M peptidyl
SNAC lnTyc-U2W8 or 75 M peptidyl thiophenol lnDap-U3W13.
Real-time measurements were performed using various time points
with slits set to 5 nm (excitation) and 5 nm (emission) at an excita-
tion wavelength of 280 nm and an emission wavelength of 452 nm.
The detector was set to medium sensitivity. All assays were
quenched by the addition of 1.6% TFA (v/v) and analyzed by analyt-
ical HPLC.
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